Guangzhou Baimi Pharmaceutical Technology Co., Ltd. is located in the Guangzhou International Business Incubator, a high-tech enterprise startup service park. It is a high-tech company specializing in the global provision of active pharmaceutical ingredients (APIs), custom synthesis of new drug intermediates, as well as related impurities and reference standards.
Founded by U.S.-trained Ph.D. holders, Guangzhou Baimi boasts a strong and youthful technical team, including 5 Ph.D. and 28 Master’s degree holders. The company’s R&D center spans 1,000 square meters and is equipped with extensive advanced experimental facilities for research and development. These include five sets of 50L high-temperature and ultra-low temperature reaction vessels, 30 fume hoods, and 3 walk-in fume hoods, enabling the simultaneous development of approximately 20 product varieties. Analytical instruments include multiple Agilent and Shimadzu HPLC and GC systems, LC-MS, preparative HPLC, a 500MHz NMR, among others. Additionally, the company operates a 480-acre production base. Guangzhou Baimi is dedicated to the R&D of high-synthesis-technology, high-difficulty, and high-value-added pharmaceutical APIs and intermediates, offering production services ranging from milligram to ton scale for global clients.
Guangzhou Baimi Pharmaceutical Technology Co., Ltd. will always remain at the forefront of the pharmaceutical industry, creating greater value for customers through cost-effective products and services, while upholding the noble mission of contributing to global health.
